IL326153A - צורות מצב מוצק של gusacitinib - Google Patents

צורות מצב מוצק של gusacitinib

Info

Publication number
IL326153A
IL326153A IL326153A IL32615326A IL326153A IL 326153 A IL326153 A IL 326153A IL 326153 A IL326153 A IL 326153A IL 32615326 A IL32615326 A IL 32615326A IL 326153 A IL326153 A IL 326153A
Authority
IL
Israel
Prior art keywords
gusacitinib
solid state
state forms
forms
solid
Prior art date
Application number
IL326153A
Other languages
English (en)
Original Assignee
Libertas Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Libertas Bio Inc filed Critical Libertas Bio Inc
Publication of IL326153A publication Critical patent/IL326153A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL326153A 2023-07-27 2024-07-26 צורות מצב מוצק של gusacitinib IL326153A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363515864P 2023-07-27 2023-07-27
PCT/US2024/039746 WO2025024765A1 (en) 2023-07-27 2024-07-26 Solid state forms of gusacitinib

Publications (1)

Publication Number Publication Date
IL326153A true IL326153A (he) 2026-03-01

Family

ID=92538749

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326153A IL326153A (he) 2023-07-27 2024-07-26 צורות מצב מוצק של gusacitinib

Country Status (7)

Country Link
EP (1) EP4750775A1 (he)
KR (1) KR20260078905A (he)
CN (1) CN122206677A (he)
AU (1) AU2024299978A1 (he)
IL (1) IL326153A (he)
TW (1) TW202510870A (he)
WO (1) WO2025024765A1 (he)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014003981A2 (pt) 2011-08-23 2017-03-07 Endo Pharmaceuticals Inc compostos de pirimido-piridazinona e seu uso
CN110809471A (zh) 2017-04-28 2020-02-18 阿沙纳生物科学公司 治疗特应性皮炎以及提高活性药物成分稳定性的制剂、方法、试剂盒和剂型
US20250171448A1 (en) * 2022-02-23 2025-05-29 Teva Pharmaceuticals International Gmbh Solid state forms of gusacitinib

Also Published As

Publication number Publication date
AU2024299978A1 (en) 2026-03-12
WO2025024765A1 (en) 2025-01-30
KR20260078905A (ko) 2026-05-29
CN122206677A (zh) 2026-06-12
TW202510870A (zh) 2025-03-16
EP4750775A1 (en) 2026-06-03

Similar Documents

Publication Publication Date Title
CA215228S (en) Set of earbuds
EP4165031A4 (en) SOLID FORMS OF CYANTRANILIPROL
CA221468S (en) Part of earphone
KR102423280B9 (ko) Sot-mram 면적 최적화 기법
GB202103774D0 (en) Detectiion of Ransomware
GB202411655D0 (en) Application of circHIF1a
IL317645A (he) שיטות להכנת טולברוטיניב
GB202011709D0 (en) Solid dispersion of opicapone
IL304159A (he) תכשיר המכיל bl-8040
IL318553A (he) וריאנטים של tdp-43 עמידים לצבירה
GB202115776D0 (en) Design of engineering components
IL326152A (he) צורות מצב מוצק של gusacitinib
IL321161A (he) צורות מוצקות של תרכובות נפתירידין
GB2612588B (en) Design of engineering components
IL319179A (he) צורות מוצקות של דניפנסטאט
CA3303749A1 (en) Solid state forms of samuraciclib
CA3299931A1 (en) Solid state forms of gusacitinib
CA3299990A1 (en) Solid state forms of gusacitinib
CA3297108A1 (en) Solid state forms of sunvozertinib
CA3294911A1 (en) Solid state forms of rencofilstat
CA3268966A1 (en) Solid state forms of denifanstat
GB202508287D0 (en) Co-amorphous solid forms of flavonoids
GB202215264D0 (en) Use of urolithins
CA234591S (en) Part of windlass
GB202301974D0 (en) The capability of becoming telepathic